Norman E J, Mooney C T
Division of Small Animal Clinical Studies, University of Glasgow Veterinary School, Bearsden Road, Glasgow.
J Feline Med Surg. 2000 Dec;2(4):183-90. doi: 10.1053/jfms.2000.0097.
The clinical findings and management of five cats with abnormalities consistent with acromegaly were examined retrospectively. Growth hormone (GH) concentrations were elevated in four cats. In one, a minimal elevation of GH was accompanied by a marked elevation in insulin-like growth factor-1 (IGF-1). Insulin-like growth factor-1 concentrations supported the diagnosis in three of four cats measured, but was not elevated initially in one cat, despite a markedly elevated GH concentration. These findings suggest that elevated IGF-1 concentrations are a reliable indicator of acromegaly, but that values within the reference range do not exclude such a diagnosis. Clinical signs of acromegaly were similar to those previously reported, although upper respiratory stridor occurred in one cat, and insulin-resistant diabetes mellitus was not a consistent feature. Despite the lack of a widely available definitive treatment for acromegaly, good control of the clinical signs of diabetes mellitus can be achieved for long periods despite high doses of insulin often being required.
对五只出现与肢端肥大症相符异常的猫的临床症状及治疗情况进行了回顾性研究。四只猫的生长激素(GH)浓度升高。其中一只猫GH仅有轻微升高,但胰岛素样生长因子-1(IGF-1)显著升高。四只接受检测的猫中,有三只猫的胰岛素样生长因子-1浓度支持肢端肥大症的诊断,但有一只猫尽管GH浓度显著升高,其胰岛素样生长因子-1浓度最初并未升高。这些发现表明,IGF-1浓度升高是肢端肥大症的可靠指标,但参考范围内的值并不能排除该诊断。肢端肥大症的临床症状与先前报道的相似,不过有一只猫出现了上呼吸道喘鸣,且胰岛素抵抗性糖尿病并非一致特征。尽管缺乏针对肢端肥大症的广泛可用的确定性治疗方法,但尽管常常需要高剂量胰岛素,仍可长期实现对糖尿病临床症状的良好控制。